Legend Biotech Corporation (LEGN)
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in revlimid-refractory multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates, which are in Phase I clinical trials for the treatment of gastric cancer and T cell lymphoma. In addition, it is developing CAR-T product candidates targeting CD20/CD22/CD19 for the treatment of non-hodgkins lymphoma, diffuse large B-cell lymphoma, and acute lymphoblastic leukemia. Further, the company has product candidates in early preclinical and clinical development for the treatment of solid tumors as well as infectious diseases. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. Legend Biotech Corporation was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation.
$9.39B
Dr. Ying Huang Ph.D.
1,071.00
Somerset, NJ
Jun 04, 2020
-33.30
$-1.45
6.12
8.01
0.09%
6.45%
1,154.68
7.14
77.37
7.83
0.45%
1.24%
Similar stocks (14)
Alnylam Pharmaceuticals, Inc.
ALNY
Vaxcyte, Inc.
PCVX
Blueprint Medicines Corporation
BPMC
Madrigal Pharmaceuticals, Inc.
MDGL
Apellis Pharmaceuticals, Inc.
APLS
Arcellx, Inc.
ACLX
Akero Therapeutics, Inc.
AKRO
Day One Biopharmaceuticals, Inc.
DAWN
89bio, Inc.
ETNB
Travere Therapeutics, Inc.
TVTX
Pliant Therapeutics, Inc.
PLRX
Stoke Therapeutics, Inc.
STOK
Terns Pharmaceuticals, Inc.
TERN
Amylyx Pharmaceuticals, Inc.
AMLX
ETF Exposure (35)
Global X Genomics & Biotechnology ETF
GNOM
4.35%
Loncar Cancer Immunotherapy ETF
CNCR
3.2%
BlackRock Future Health ETF
BMED
1.14512%
iShares Biotechnology ETF
IBB
0.80045%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.463%
T. Rowe Price Growth Stock ETF
TGRW
0.27404%
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
0.23535%
iShares MSCI China ETF
MCHI
0.21341%
Vanguard Health Care Fund Admiral Shares
VGHAX
0.18%
Vanguard Health Care Fund
VGHCX
0.18%
SPDR S&P China ETF
GXC
0.141486%
First Trust Nasdaq BuyWrite Income ETF
FTQI
0.14%
ProShares Ultra Nasdaq Biotechnology
BIB
0.1273864938901089%
SPDR S&P Kensho New Economies Composite ETF
KOMP
0.122668%
iShares MSCI BIC ETF
BKF
0.10458%
iShares MSCI Global Min Vol Factor ETF
ACWV
0.08321%
SPDR S&P Emerging Asia Pacific ETF
GMF
0.076432%
Harbor Health Care ETF
MEDI
0.0753774966%
SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
0.073151%
iShares MSCI Emerging Markets Asia ETF
EEMA
0.06625%
iShares MSCI All Country Asia ex Japan ETF
AAXJ
0.06191%
iShares MSCI Emerging Markets ETF
EEM
0.05198%
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
0.04853503%
SPDR MSCI Emerging Markets Fossil Fuel Reserves Free ETF
EEMX
0.046764%
SPDR Portfolio Emerging Markets ETF
SPEM
0.044178%
iShares Core MSCI Emerging Markets ETF
IEMG
0.04373%
SPDR MSCI ACWI ex-US ETF
CWI
0.021329%
Fidelity Nasdaq Composite Index ETF
ONEQ
0.02%
Xtrackers MSCI All World ex U.S. Hedged Equity ETF
DBAW
0.01875798%
iShares MSCI ACWI ex U.S. ETF
ACWX
0.01434%
iShares Core MSCI Total International Stock ETF
IXUS
0.01271%
Harbor Disruptive Innovation ETF
INNO
0.0063307126%
iShares MSCI ACWI ETF
ACWI
0.00538%
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
4.959e-4%
KraneShares MSCI All China Health Care Index ETF
KURE
0%
Similar stocks (14)
Alnylam Pharmaceuticals, Inc.
ALNY
Vaxcyte, Inc.
PCVX
Blueprint Medicines Corporation
BPMC
Madrigal Pharmaceuticals, Inc.
MDGL
Apellis Pharmaceuticals, Inc.
APLS
Arcellx, Inc.
ACLX
Akero Therapeutics, Inc.
AKRO
Day One Biopharmaceuticals, Inc.
DAWN
89bio, Inc.
ETNB
Travere Therapeutics, Inc.
TVTX
Pliant Therapeutics, Inc.
PLRX
Stoke Therapeutics, Inc.
STOK
Terns Pharmaceuticals, Inc.
TERN
Amylyx Pharmaceuticals, Inc.
AMLX
ETF Exposure (35)
Global X Genomics & Biotechnology ETF
GNOM
4.35%
Loncar Cancer Immunotherapy ETF
CNCR
3.2%
BlackRock Future Health ETF
BMED
1.14512%
iShares Biotechnology ETF
IBB
0.80045%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.463%
T. Rowe Price Growth Stock ETF
TGRW
0.27404%
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
0.23535%
iShares MSCI China ETF
MCHI
0.21341%
Vanguard Health Care Fund Admiral Shares
VGHAX
0.18%
Vanguard Health Care Fund
VGHCX
0.18%
SPDR S&P China ETF
GXC
0.141486%
First Trust Nasdaq BuyWrite Income ETF
FTQI
0.14%
ProShares Ultra Nasdaq Biotechnology
BIB
0.1273864938901089%
SPDR S&P Kensho New Economies Composite ETF
KOMP
0.122668%
iShares MSCI BIC ETF
BKF
0.10458%
iShares MSCI Global Min Vol Factor ETF
ACWV
0.08321%
SPDR S&P Emerging Asia Pacific ETF
GMF
0.076432%
Harbor Health Care ETF
MEDI
0.0753774966%
SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
0.073151%
iShares MSCI Emerging Markets Asia ETF
EEMA
0.06625%
iShares MSCI All Country Asia ex Japan ETF
AAXJ
0.06191%
iShares MSCI Emerging Markets ETF
EEM
0.05198%
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
0.04853503%
SPDR MSCI Emerging Markets Fossil Fuel Reserves Free ETF
EEMX
0.046764%
SPDR Portfolio Emerging Markets ETF
SPEM
0.044178%
iShares Core MSCI Emerging Markets ETF
IEMG
0.04373%
SPDR MSCI ACWI ex-US ETF
CWI
0.021329%
Fidelity Nasdaq Composite Index ETF
ONEQ
0.02%
Xtrackers MSCI All World ex U.S. Hedged Equity ETF
DBAW
0.01875798%
iShares MSCI ACWI ex U.S. ETF
ACWX
0.01434%
iShares Core MSCI Total International Stock ETF
IXUS
0.01271%
Harbor Disruptive Innovation ETF
INNO
0.0063307126%
iShares MSCI ACWI ETF
ACWI
0.00538%
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
4.959e-4%
KraneShares MSCI All China Health Care Index ETF
KURE
0%